Evidence map›Paper›PMID 27763641›Full record

ArticleCell death & disease2016

PKN2 and Cdo interact to activate AKT and promote myoblast differentiation.

Sang-Jin Lee, Jeongmi Hwang, Hyeon-Ju Jeong, Miran Yoo, Ga-Yeon Go, Jae-Rin Lee, Young-Eun Leem, Jong Woo Park, Dong-Wan Seo, Yong Kee Kim and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. TRIM40 Drives Pathological Cardiac Hypertrophy and Heart Failure via Ubiquitination of PKN2.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Genomic Landscape and Prediction of Udder Traits in Saanen Dairy Goats.Animals : an open access journal from MDPI · 2025
    Article
  6. Review
  7. Muscle-specific pyruvate kinase isoforms, PKM1 and PKM2, regulate mammalian SWI/SNF proteins and histone 3 phosphorylation during myoblast differentiation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Sang-Jin LeeResearch Center for Cell Fate Control, College of Pharmacy, Department of Cell Therapy, Sookmyung Women's University, Seoul, Republic of Korea.
Jeongmi HwangResearch Center for Cell Fate Control, College of Pharmacy, Department of Cell Therapy, Sookmyung Women's University, Seoul, Republic of Korea.
Hyeon-Ju JeongDepartment of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Samsung Biomedical Research Institute, Suwon, Republic of Korea.
Miran YooResearch Center for Cell Fate Control, College of Pharmacy, Department of Cell Therapy, Sookmyung Women's University, Seoul, Republic of Korea.
Ga-Yeon GoResearch Center for Cell Fate Control, College of Pharmacy, Department of Cell Therapy, Sookmyung Women's University, Seoul, Republic of Korea.
Jae-Rin LeeDepartment of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Samsung Biomedical Research Institute, Suwon, Republic of Korea.
Young-Eun LeemDepartment of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Samsung Biomedical Research Institute, Suwon, Republic of Korea.
Jong Woo ParkResearch Center for Epigenome Regulation, School of Pharmacy, Department of Biochemistry and Molecular Biology, Sungkyunkwan University, Suwon, Republic of Korea.
Dong-Wan SeoCollege of Pharmacy, Department of Biochemistry, Dankook University, Cheonan, Republic of Korea.
Yong Kee KimResearch Center for Cell Fate Control, College of Pharmacy, Department of Cell Therapy, Sookmyung Women's University, Seoul, Republic of Korea.
Myong-Joon HahnDepartment of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Samsung Biomedical Research Institute, Suwon, Republic of Korea.
Jeung-Whan HanResearch Center for Epigenome Regulation, School of Pharmacy, Department of Biochemistry and Molecular Biology, Sungkyunkwan University, Suwon, Republic of Korea.
Jong-Sun KangDepartment of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Samsung Biomedical Research Institute, Suwon, Republic of Korea.
Gyu-Un BaeResearch Center for Cell Fate Control, College of Pharmacy, Department of Cell Therapy, Sookmyung Women's University, Seoul, Republic of Korea.
Sookmyung Women's University · KRSungkyunkwan University · KRSamsung (South Korea) · KRDankook University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skeletal myogenesis is coordinated by multiple signaling pathways that control cell adhesion/migration, survival and differentiation accompanied by muscle-specific gene expression. A cell surface protein Cdo is involved in cell contact-mediated promyogenic signals through activation of p38MAPK and AKT. Protein kinase C-related kinase 2 (PKN2/PRK2) is implicated in regulation of various biological processes, including cell migration, adhesion and death. It has been shown to interact with and inhibit AKT thereby inducing cell death. This led us to investigate the role of PKN2 in skeletal myogenesis and the crosstalk between PKN2 and Cdo. Like Cdo, PKN2 was upregulated in C2C12 myoblasts during differentiation and decreased in cells with Cdo depletion caused by shRNA or cultured on integrin-independent substratum. This decline of PKN2 levels resulted in diminished AKT activation during myoblast differentiation. Consistently, PKN2 overexpression-enhanced C2C12 myoblast differentiation, whereas PKN2-depletion impaired it, without affecting cell survival. PKN2 formed complexes with Cdo, APPL1 and AKT via its C-terminal region and this interaction appeared to be important for induction of AKT activity as well as myoblast differentiation. Furthermore, PKN2-enhanced MyoD-responsive reporter activities by mediating the recruitment of BAF60c and MyoD to the myogenin promoter. Taken together, PKN2 has a critical role in cell adhesion-mediated AKT activation during myoblast differentiation.

Indexed as

Cell DifferentiationAdaptor Proteins, Signal TransducingAnimalsCell Adhesion MoleculesCell LineEnzyme ActivationGenes, ReporterMiceMyoblastsMyoD ProteinProtein BindingProtein Kinase CProto-Oncogene Proteins c-aktTwo-Hybrid System TechniquesUp-RegulationAdaptor Proteins, Signal TransducingAppl1 protein, mouseCdon protein, mouseCell Adhesion MoleculesMyoD ProteinProtein Kinase Cprotein kinase NProto-Oncogene Proteins c-akt

Identifiers

PMID27763641
PMCPMC5133968
OpenAlexW2534094361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.